99.70%Reported RP-HPLC area purity
99.72%Reported RP-HPLC area purityFind Your GLOW Batch Report
Select the report that matches the lot number on your vial. Each original certificate includes the lot-release summary, chromatogram, analytical methods, peak table, mass-spectrometry results, and approval record.[1, 2]
GLOW Blend 50 mg
35 mg GHK-Cu / 5 mg BPC-157 / 10 mg TB-500
Overall report conclusion: PASS
- Lot / batch
- PL-2609-042
- Certificate
- PL-26-00042
- Analysis date
- 18 September 2026
- Issued
- 3 October 2026
- Issuer
- PrymaLab Analytical (in-house)
- Original document
- 2 pages
GLOW Blend 70 mg
50 mg GHK-Cu / 10 mg BPC-157 / 10 mg TB-500
Overall report conclusion: PASS
- Lot / batch
- PL-2609-043
- Certificate
- PL-26-00043
- Analysis date
- 17 September 2026
- Issued
- 3 October 2026
- Issuer
- PrymaLab Analytical (in-house)
- Original document
- 2 pages
No matching document in this two-report library. Check the identifier or contact us about the record you need.
This library provides the two original documents. The issuer's separate verification service is linked below; filtering this library does not authenticate a certificate.
What the GLOW Certificates Report
The table below transcribes the results from page 1 of each certificate. Every listed row is marked PASS by the issuing laboratory. The report's overall conclusion is that the tested samples meet the listed specifications.[1, 2]
| Test | Method in report | 50 mg · PL-2609-042 | 70 mg · PL-2609-043 |
|---|---|---|---|
| Appearance | Visual inspection | Blue lyophilized cake | Blue lyophilized cake |
| Identity (mass) | LC-MS, ESI positive | 3/3 components confirmed | 3/3 components confirmed |
| Purity | RP-HPLC, UV 214 nm, area% | 99.70% | 99.72% |
| Largest impurity | RP-HPLC, area% | 0.11% at 6.92 min | 0.10% at 5.32 min |
| Water content | Karl Fischer | 2.0% | 2.0% |
| Bacterial endotoxin | LAL, kinetic | 0.05 EU/mg | 0.05 EU/mg |
| Sterility / bioburden | USP <71>, membrane filtration | No growth; conforms | No growth; conforms |
Identity results, by component
Both certificates list observed deconvoluted masses of 402.1 / 1419.8 / 4963.7 Da, compared with theoretical values of 401.9 / 1419.6 / 4963.5 Da for GHK-Cu, BPC-157, and TB-500 (Thymosin β4), respectively. The stated acceptance is within ±1.0 Da for each component.[1, 2]
Read PASS in its stated scope. It is the laboratory's conclusion for the tests performed on the named lot's sampled units, not a clinical outcome or a claim about every batch.
See the Original Chromatograms
Each report shows three named component peaks and additional peaks, with retention times and area percentages. These images are excerpts from the supplied certificates, not newly generated test data.[1, 2]
GLOW 50 mg
Lot PL-2609-042 · Reported purity 99.70%
GLOW 70 mg
Lot PL-2609-043 · Reported purity 99.72%
Peak table: reported area percentages
| Peak label | Retention time (min) | 50 mg area % | 70 mg area % |
|---|---|---|---|
| GHK-Cu | 2.20 | 70.00 | 71.26 |
| BPC-157 | 4.68 | 9.95 | 14.12 |
| Other peak | 5.32 | 0.10 | 0.10 |
| TB-500 | 6.08 | 19.75 | 14.34 |
| Other peak | 6.92 | 0.11 | 0.08 |
| Other peak | 7.58 | 0.09 | 0.10 |
| Total integrated area | — | 100.00% | 100.00% |
On page 1, the issuer describes blend purity as the sum of the three component peaks. The named peak percentages shown above add to the reported 99.70% and 99.72%. These are chromatographic area figures; the separate composition statements below describe the labeled ingredient amounts.
The complete peak tables, raw area values, gradient programs and method details remain available on page 2 of each original PDF. No analytical data has been edited in the documents.
Know the Formulation and the Test Method
The certificates identify two distinct co-lyophilized formulations. The quantities below reproduce the Composition and Sequences section of each document; they are labeled composition, not an additional quantitative assay performed by this website.[1, 2]
35 / 5 / 10 mg
Lot PL-2609-042
Label claim: 50 mg/vial
50 / 10 / 10 mg
Lot PL-2609-043
Label claim: 70 mg/vial
Both documents name GHK-Cu as the GHK copper(II) 1:1 complex, BPC-157 as a 15-residue peptide, and TB-500 (Thymosin β4) as a 43-residue, N-acetyl peptide with a free C-terminus. Those are the identities stated in these certificates.[1, 2]
Analytical method recorded on page 2
The listed mobile phases are 0.1% TFA in water and 0.1% TFA in MeCN. Both reports identify an in-house reference, lot PL-RS-GLO-01, and record that a blank was injected. These are laboratory instrument settings, not product-preparation or administration instructions.[1, 2]
From Analysis to Lot Release
The two certificates were issued on 3 October 2026. Each identifies a lot of 250 units with 2 units sampled. The dates below come from the lot metadata, additional-tests register, and review-and-approval sections.[1, 2]
50 mg · PL-2609-042
- 16 Sep 2026Date made
- 18 Sep 2026Analysis / analyst date
- 19 Sep 2026Water-content test
- 20 Sep 2026Endotoxin test
- 2 Oct 2026Sterility test / reviewer date
- 3 Oct 2026Lab Director approval / issued
70 mg · PL-2609-043
- 15 Sep 2026Date made
- 17 Sep 2026Analysis / analyst date
- 18 Sep 2026Water-content test
- 19 Sep 2026Endotoxin test
- 1 Oct 2026Sterility test
- 2–3 Oct 2026Reviewer, then Lab Director approval / issue
Storage and retest dates stated in the reports
| Record | 50 mg vial lot | 70 mg vial lot |
|---|---|---|
| Storage | −20 °C, desiccated, dark | −20 °C, desiccated, dark |
| Retest / expiry | 16 September 2028 | 15 September 2028 |
| Units in lot / sampled | 250 / 2 | 250 / 2 |
Both approval records name D. Reynolds as analyst, S. Calloway as reviewer, and M. Phelps as Lab Director. The documents state that raw data are retained in the listed Empower archive for seven years. This is the issuer's documented record, not a review of that archive by this website.[1, 2]
These storage and retest entries concern the named lyophilized vial lots. They do not describe an after-mixing storage period.
Check the Certificate with the Issuer
Each original PDF contains a QR code, a certificate number, and a verification key. The issuer instructs readers to scan the QR code or enter both identifiers at prymalab.net/testing/verify.[1, 2]
PL-26-00042
BL5CVBZMPL-26-00043
86MP9DE8Match the lot
Compare the batch number on your vial with the certificate.
Open the issuer's site
Use the QR code in the PDF or the verification link below.
Compare the record
Check the certificate number, key and returned document details.
Opens the external issuer's service. This page displays the supplied documents and verification details; it does not show an automated or independently completed authentication result.
Who performed the testing?
PrymaLab Analytical, the manufacturer's own laboratory. Both certificates explicitly identify the testing as in-house and state that no outside-laboratory reports are attached. They apply only to their named lots and sampled units, not to other lots.[1, 2]
The originals remain unchanged, including their issuer, signatures, verification details, and research-use statement. Read our Editorial Policy for how manufacturer records are presented.
GLOW Autoinjector: Product Specification
3 mL preloaded format
The supplied pen specification lists GHK-Cu 107 mg, BPC-157 21.4 mg, and TB-500 (Thymosin β4) 21.4 mg per 3 mL pen, with a nominal 150 mg total and 50 mg/mL labeled blend concentration.[3]
It describes a sterile aqueous solution in bacteriostatic water with 0.9% benzyl alcohol, supplied in a 3 mL glass cartridge inside the autoinjector. Sealed storage is stated as 2–8 °C, in the original carton, protected from light.[3]
View supplied specification excerpt ↗This panel summarizes manufacturer product specifications. Analytical result summaries elsewhere on this page identify the applicable vial lot and certificate.
GLOW Quality + COA: Frequently Asked Questions
Where can I download the original GLOW COAs?
Open the 50 mg or 70 mg report in the certificate library. Each download contains both original pages, including the chromatogram, method, peak table, and approval record.
Is the testing independent or third-party?
What does the purity percentage describe?
Does the report identify all three components?
Are water content, endotoxin and sterility included?
Does this report apply to every GLOW vial?
How do I check authenticity?
Follow the issuer's QR code or enter the certificate number and verification key at the linked verification service. Compare the returned record with the original document; the two identifiers are available in the verification section.[1, 2]
Who should I contact about a batch document?
Use our Contact page and include the product name, lot number, and certificate number. Identify the field or result your question concerns so the record can be checked without guessing.
Choose Your GLOW Format
Compare the two vial formulations or view the preloaded autoinjector. Review the relevant product details before ordering.
For laboratory research use only. Not for human or veterinary use. Editorial and commercial disclosure.
Original Documents and Source Notes
The result tables and previews on this page are drawn from the two supplied certificates. Pen information is kept as manufacturer specification data. The PDF files are provided without alteration.
- 1GLOW Blend 50 mg · PL-26-00042
PrymaLab Analytical, in-house laboratory. Lot PL-2609-042. Issued 3 October 2026. Page 1: composition, results and chromatogram. Page 2: methods, peak table, identity and approval.
- 2GLOW Blend 70 mg · PL-26-00043
PrymaLab Analytical, in-house laboratory. Lot PL-2609-043. Issued 3 October 2026. Page 1: composition, results and chromatogram. Page 2: methods, peak table, identity and approval.
- 3GLOW autoinjector specification excerpt
User-supplied manufacturer specification screenshot identifying contents, form, sealed storage, and safety data sheet reference PL-SDS-070. Used for specification details, not vial test results.
A certificate is a report from its issuer. This page does not claim independent reproduction of the testing or access to the retained raw-data archive. For corrections or documentation questions, contact the publisher.